Pro Share Advisors LLC Denali Therapeutics Inc. Transaction History

Pro Share Advisors LLC

$39.7 Billion
Q3 2024

A detailed history of Pro Share Advisors LLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 31,948 shares of DNLI stock, worth $803,811. This represents 0.0% of its overall portfolio holdings.

Number of Shares

31,948

Previous 24,798 28.83%

Holding current value

$803,811

Previous $575,000 61.74%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$20.96 - $31.05 $149,864 - $222,007	7,150 Added 28.83%	31,948 $930,000
Q2 2024 Aug 13, 2024	SELL	$14.96 - $23.22 $95,848 - $148,770	-6,407 Reduced 20.53%	24,798 $575,000
Q1 2024 May 08, 2024	BUY	$15.83 - $23.35 $44,640 - $65,847	2,820 Added 9.93%	31,205 $640,000
Q4 2023 Feb 14, 2024	BUY	$16.2 - $23.18 $65,658 - $93,948	4,053 Added 16.66%	28,385 $609,000
Q3 2023 Nov 13, 2023	BUY	$20.63 - $30.17 $2,248 - $3,288	109 Added 0.45%	24,332 $501,000
Q2 2023 Aug 10, 2023	BUY	$23.37 - $32.96 $45,267 - $63,843	1,937 Added 8.69%	24,223 $714,000
Q1 2023 May 11, 2023	SELL	$21.91 - $32.67 $101,268 - $151,000	-4,622 Reduced 17.18%	22,286 $513,000
Q4 2022 Feb 02, 2023	BUY	$26.28 - $33.92 $108,247 - $139,716	4,119 Added 18.07%	26,908 $748,000
Q3 2022 Nov 04, 2022	BUY	$25.97 - $38.53 $15,971 - $23,695	615 Added 2.77%	22,789 $700,000
Q2 2022 Aug 01, 2022	SELL	$20.88 - $35.19 $202,682 - $341,589	-9,707 Reduced 30.45%	22,174 $653,000
Q1 2022 May 10, 2022	SELL	$29.0 - $47.27 $218,109 - $355,517	-7,521 Reduced 19.09%	31,881 $1.03 Million
Q4 2021 Feb 08, 2022	SELL	$42.59 - $55.02 $18,526 - $23,933	-435 Reduced 1.09%	39,402 $1.76 Million
Q3 2021 Nov 12, 2021	SELL	$48.48 - $78.23 $267,852 - $432,220	-5,525 Reduced 12.18%	39,837 $2.01 Million
Q2 2021 Aug 13, 2021	BUY	$50.3 - $78.44 $592,785 - $924,415	11,785 Added 35.1%	45,362 $3.56 Million
Q1 2021 May 14, 2021	BUY	$53.8 - $81.53 $61,278 - $92,862	1,139 Added 3.51%	33,577 $1.92 Million
Q4 2020 Feb 09, 2021	BUY	$36.89 - $93.56 $282,245 - $715,827	7,651 Added 30.87%	32,438 $2.72 Million
Q3 2020 Nov 13, 2020	SELL	$23.13 - $38.84 $14,733 - $24,741	-637 Reduced 2.51%	24,787 $888,000
Q2 2020 Aug 03, 2020	BUY	$16.01 - $28.82 $146,411 - $263,558	9,145 Added 56.18%	25,424 $615,000
Q1 2020 May 15, 2020	SELL	$14.2 - $27.98 $156,015 - $307,416	-10,987 Reduced 40.3%	16,279 $285,000
Q4 2019 Feb 12, 2020	SELL	$14.4 - $19.99 $59,385 - $82,438	-4,124 Reduced 13.14%	27,266 $475,000
Q3 2019 Nov 12, 2019	SELL	$15.32 - $21.92 $19,900 - $28,474	-1,299 Reduced 3.97%	31,390 $481,000
Q2 2019 Aug 13, 2019	SELL	$18.5 - $28.14 $83,657 - $127,249	-4,522 Reduced 12.15%	32,689 $679,000
Q1 2019 May 15, 2019	BUY	$17.99 - $24.65 $4,065 - $5,570	226 Added 0.61%	37,211 $864,000
Q4 2018 Feb 14, 2019	BUY	$13.88 - $21.75 $513,351 - $804,423	36,985 New	36,985 $764,000

Others Institutions Holding DNLI

# of Institutions

228

Shares Held

120M

Call Options Held

60.6K

Put Options Held

48.4K

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $3.38B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Denali Therapeutics Inc. Transaction History